Protein kinase C (PKC) is a major intracellular threonine-serine kinase that has been implicated in a large number of signal transduction processes that mediate extracellular signals into intracellular events. For maximal activity PKC requires cofactors, most notably Ca 2+ and diacylglycerol (DAG). In this respect phorbol esters have proved valuable pharmacological tools for examining the role of PKC in physiological processes because they irreversibly activate PKC through attachment to its DAG-binding domain.
Protein kinase C (PKC) is a major intracellular threonine-serine kinase that has been implicated in a large number of signal transduction processes that mediate extracellular signals into intracellular events. For maximal activity PKC requires cofactors, most notably Ca 2+ and diacylglycerol (DAG) . In this respect phorbol esters have proved valuable pharmacological tools for examining the role of PKC in physiological processes because they irreversibly activate PKC through attachment to its DAG-binding domain.
One important signal transduction process is that which occurs at fertilization, where the spermatozoon triggers oocyte activation. I have examined evidence of a role for PKC in three major events associated with mammalian oocyte fertilization: (1) periodic increases in intracellular Ca 2+ (Ca 2+ oscillations); (2) release of cortical granules (CGs) which block polyspermy; and (3) release from meiotic arrest. The reason for listing an increase in Ca 2+ first is that it is the primary trigger for the subsequent two events. That is, by blocking changes in cytoplasmic Ca 2+ both release of CGs and meiotic resumption are inhibited (Kline and Kline, 1992) . This review outlines the evidence implicating PKC in these three processes.
This review has been limited to mammalian oocytes since there are subtle differences in the events associated with fertilization in other species, such as the widely studied sea urchin, which make comparisons difficult. For example, in sea urchin eggs, but not mammalian oocytes, a membrane depolarization is responsible for a fast block to polyspermy (Jaffe, 1976; Jaffe et al., 1983) , a 'respiratory burst' occurs after egg activation (Heinecke and Shapiro, 1989 ) and a cytoplasmic alkalinization occurs (Whitaker and Steinhardt, 1982; Kline and Zagray, 1995) . Sea urchin eggs also show a single Ca 2+ wave, lasting 24 s (Whitaker and Irvine, 1984) , compared with the series of Ca 2+ oscillations in mammals that are observed over a period of several hours (Jones et al., 1995) . Furthermore, sea urchin eggs are arrested in interphase, having completed meiosis, rather than at metaphase II, as is the case with mammalian oocytes. In addition, the eggs of some animals, such as molluscs, do not release cortical granules to block polyspermy. In light of these observations, and for clarity, I have focused on mammalian oocytes.
Protein kinase C and increasing intracellular Ca 2+
It may seem odd to ask whether PKC has a role in raising intracellular Ca 2+ , when it is well known that PKC is a target for Ca 2+ action. However, the question is raised because of the studies carried out by Cuthbertson and Cobbold (1985) which made the first direct measurement of sperm-induced Ca 2+ oscillations in mammalian (mouse) oocytes. Cuthbertson and Cobbold found that application of 325 nmol l -1 of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) could induce Ca 2+ oscillations in mouse oocytes, albeit with a delay of at least 30 min. Higher concentrations induced oscillations more quickly, but still with a delay of up to 10 min. A similar ability of TPA at comparably high concentrations to increase intracellular Ca 2+ concentrations has been noted in human keratinocytes, over a similar time course to that observed in oocytes (Sharpe et al., 1989) .
The ability of TPA to induce oscillations in oocytes with a delay has not been shown by other researchers to my knowledge. More recent studies have confirmed the original finding that there is not an immediate increase in Ca 2+ after addition of TPA (Colonna et al., 1989; Moses and Kline, 1995) . In some studies, TPA seems actually to mitigate or even inhibit sperm-induced oscillations. In hamster oocytes, it decreases At fertilization, the spermatozoon is generally held to generate two important second messengers, inositol trisphosphate and diacylglycerol. A similar situation arises when these signalling molecules are generated after a hormone binds to its plasma membrane receptor. This signalling mechanism releases intracellular Ca 2+ which causes cortical granule release and initiates meiotic resumption. This review will examine the role played at fertilization by protein kinase C which is a primary target of diacylglycerol. The pharmacological agents phorbol esters, which mimic the action of diacylglycerol, when added to mammalian oocytes induce cortical granule release and may cause meiotic resumption. However, the originally accepted mechanism of fertilization is now questioned with the recent finding of a soluble sperm Ca 2+ -releasing factor expelled directly into the oocyte cytoplasm, bypassing any membrane receptor. Therefore, it is timely to re-evaluate the role played by protein kinase C at fertilization in light of a mechanism that may produce Ca 2+ without producing diacylglycerol concomitantly. This article will examine the evidence implicating activation of protein kinase C in Ca 2+ oscillations, cortical granule release and meiotic resumption. It will contend that pharmacological studies relying on the specificity of phorbol esters and other agonists, as well as inhibitors of protein kinase C, have produced conflicting interpretations of the role of this kinase at fertilization. the frequency of oscillations when added before spermatozoa (Swann et al., 1989) , whereas in human oocytes, it eventually stops the oscillations whether added before or after spermatozoa (Sousa et al., 1996) .
We are left to conclude that the signal at fertilization is not PKC activation, leading to Ca 2+ oscillations and then to release from meiosis. Although the initial study seemed to suggest this, high doses were required and lower doses did not affect intracellular Ca 2+ immediately. In hamsters, the first Ca 2+ transient occurs within 30 s after sperm-oocyte fusion (Miyazaki et al., 1986) , while in mice, there is a longer delay but by only a few minutes (Lawrence et al., 1997) . Therefore, the timing is wrong for PKC to be involved in the generation of Ca 2+ oscillations. Ca 2+ oscillations must be induced immediately by application of TPA. It is interesting to note that a protein kinase inhibitor, staurosporine, which is often used to inhibit PKC, also causes an increase in intracellular Ca 2+ in oocytes if used at a high enough concentration (Fig. 1) .
Protein kinase C and release of cortical granules
If PKC has a role at fertilization, it must be possible to mimic the events of fertilization by phorbol esters. There is some evidence to suggest that this is so for the block to polyspermy which occurs minutes after sperm-oocyte fusion. Phorbol esters, by activating PKC, cause some of the changes associated with the zona after fertilization. Endo et al. (1987) showed that phorbol esters added to zona-intact mouse oocytes prevent sperm penetration and, therefore, fertilization. This was attributed to changes in the zona since its removal gave normal rates of penetration in oocytes treated with TPA. At a molecular level, TPA increased the conversion of the zona glycoprotein ZP2 to ZP2f after fertilization which is believed to be responsible in part for the subsequent block of the zona to polyspermy.
After fertilization, the changes in ZP2 and also ZP3 are caused by release of CGs from the oocyte. Therefore, it should be possible to induce their release using phorbol esters. Ducibella et al. (1993) measured the loss of CGs from the oocyte cytoplasm and found that, within 1 h of its addition, TPA led to a decrease in the number of CGs to 25-33% of controls. Within 2 h of addition of TPA, similar CG loss and ZP2 conversion occurred as in fertilized oocytes.
In one study, the PKC activator 1-oleyl-2-acetyl-sn-glycerol (OAG) was used to assess the role of PKC in mouse oocytes at fertilization (Colonna and Tatone, 1993) . OAG is structurally similar to the endogenously produced DAG but lacks a long chain fatty acid in the number 2 position. OAG, like TPA, caused CG release but this effect was not blocked by inhibitors of PKC and the authors concluded that CG release was a PKCindependent event. However, studies such as this are complicated by the specificity, or lack of it, of both activators and inhibitors.
The fact that phorbol esters are able to induce CG release does not show that PKC is actually activated at fertilization. The most convincing evidence to date against a role for PKC in the release of CGs at fertilization was presented in an elegant study by Ducibella and LeFevre (1997) . In this they blocked CG release induced by phorbol esters using known PKC inhibitors but found that these same inhibitors failed to have any effect on the extent of CG release caused by spermatozoa. This suggests there is a biochemical pathway in oocytes in which PKC activation leads to CG release but that this pathway is not used by the spermatozoon at fertilization.
Protein kinase C and release from meiotic arrest
The morphological events associated with meiotic resumption include extrusion of the second polar body and formation of pronuclei. The most important biological assay for meiotic resumption is a decrease in maturation promoting factor (MPF) activity, which is high in metaphase II oocytes but declines rapidly after oocyte activation. MPF activity in extracts prepared from oocytes is determined by its ability to phosphorylate exogenously added histone H1.
At present, it remains disputed whether phorbol esters actually activate mammalian oocytes (compare Gallicano et al. (1993) with Moore et al. (1995) ). This may seem surprising given the obvious criteria for activation. However, the assessment of activation seems to depend on the mammal studied. For example, in polar body formation, the simplest criterion for activation, phorbol esters can induce second polar body extrusion in hamster oocytes but the polar body is quickly resorbed (Gallicano et al., 1993; Moore et al., 1995) . In Syrian hamsters, up to 50% of oocytes that extrude a polar body resorb them within 1 h of addition of TPA (Gallicano et al., 1993) . This polar body may not even be a bona fide polar body because cytokinesis does not take place (Moore et al., 1995) and its formation may be due to the ability of PKC activation to disrupt the metaphase spindle, which is rapidly lost after addition of phorbol ester, or to disrupt cytoskeletal structure (Moore et al., 1995) . In mouse oocytes, it appears that phorbol esters do not induce second polar body formation (Cuthbertson and Cobbold, 1985; Colonna et al., 1989; Moore et al., 1995; Moses and Kline, 1995) . Although Gallicano et al. (1997a) have shown polar body formation in the CD-1 strain of mouse, the polar body is resorbed after a few hours, similar to the case in hamsters.
Is there any other evidence to suggest PKC is involved in second polar body extrusion? PKC itself contains a pseudosequence that binds to its ligand-binding domain, keeping PKC inactive. A myristoylated, hence membrane-anchored, version of this pseudosequence blocks the second polar body formation induced by Ca 2+ ionophore and importantly spermatozoa (Gallicano et al., 1997a) , presumably by binding to activated PKC. This suggests that, at least in part, second polar body formation is reliant on PKC activation. Alternatively, the view may be taken that loading the oocyte membrane with the pseudosequence interferes indiscriminately with the normal signalling pathway required for polar body extrusion. Interpretation of this observation is difficult for two reasons. First, there is not an appropriate control peptide lacking the myristolylated pseudosequence effect. The pharmacological agent okadaic acid, which is used as a phosphatase 1 and 2A inhibitor, will also block polar body extrusion during oocyte maturation by interfering with cytoskeletal structure (Alexandre et al., 1991) . Therefore, it cannot be certain that the myristoylated pseudosequence is acting in a precise, targeted manner. Second, Ducibella and LeFevre (1997) examined this myristoylated pseudosequence over a similar dose range to the one used by Gallicano et al. (1997a) and found it to be highly toxic. What is clear is that extrusion of the second polar body is the default pathway that will occur in the absence of any hindrance. What is unclear is how either activation of PKC through phorbol ester or inhibition through myristoylated pseudosequence will lead to a block in polar body extrusion.
In relation to pronucleus formation, there are studies that have found high rates of TPA-induced activation of mouse oocytes as assessed by pronucleus formation (Cuthbertson and Cobbold, 1985; Colonna et al., 1989; Moses and Kline, 1995) , whereas Moore et al.(1995) found the formation of pronuclei to be dependent on the mouse strain used, with oocytes from the CD-1 strain but not those from the CF-1 strain showing readily discernible pronuclei. It seems that mice such as MF1 (Cuthbertson and Cobbold, 1985) and CD-1 (Colonna et al., 1989; Moses and Kline, 1995) show pronucleus formation in response to phorbol esters, while CF-1 do not (Moore et al, 1995) ; all are outbred strains. In inbred C57BL/6JLac + CBA/CaLac F 1 hybrid mice, there is no readily discernible second polar body or pronuclei formed by application of TPA (K. T. Jones, unpublished). It must be concluded that in some strains of mouse phorbol esters do induce pronucleus formation but this is not a universal phenomenon.
It might be predicted that entry into interphase is accompanied by a fall in MPF activity since MPF declines rapidly after metaphase (Verlhac et al., 1994) . However, with respect to TPA, experimental evidence is limited to one study which suggests that, at least within 1 h of its addition, there is no decrease in MPF (Moore et al., 1995) . If it is to play a part in meiotic resumption, PKC must exert its effects downstream of MPF, causing activation even in the presence of high concentrations of MPF. Is it possible to achieve meiotic resumption even in the presence of high concentrations of MPF? A study by Bement and Capco (1991) suggested that sperm head chromatin introduced into frog eggs can be induced to decondense by TPA while MPF activity remains high, although it remains to be seen whether this is observed in general. At least in the parthenotes generated by TPA of the CD-1 mouse, the pronuclei show bromodeoxyuridine staining which suggests that they have entered S-phase (Moore et al., 1995) .
It must be concluded that phorbol esters are poor activators of oocytes showing, at best, only some criteria of normal activation. In comparison, the parthenogenetic agents of strontium, ethanol and the calcium ionophore A23187 are regarded as activating agents without contention. A high proportion of oocytes degenerate when treated with phorbol esters, a dramatic illustration of which was shown by a study of 43 oocytes treated with 162 nmol TPA l -1 for only 10 min in which 16 degenerated, 24 formed pronuclei and three remained arrested at metaphase II (Moses and Kline, 1995). There appears to be a thin line between degeneration and activation.
It is unfortunate that much of the study of PKC at fertilization has been limited to pharmacological manipulation that relies heavily on phorbol esters. These agents are not specific for binding to PKC (Ahmed et al., 1993; Wilkinson and Hallam, 1994; Kazanietz et al., 1995) and, therefore, their use should be examined critically.
There are alternative methods for assaying PKC for activity at fertilization. The first is to use the addition of a known substrate and radiolabelled ATP. The MARCKS (myristoylated alanine-rich C-kinase substrate) protein is a suitable substrate, being readily phosphorylated by PKC. After fertilization, there is an increase in MARCKS phosphorylation (Gallicano et al., 1997a) which may be abolished by a bisindolylmaleimide. On the basis of their similarity to the indolocarbazole staurosporine, bisindolylmaleimides have been developed as specific PKC inhibitors. Bisindolylmaleimides interfere with the ATPbinding domain of kinases, and have specificity for PKC over other kinases. The crucial questions here are: (1) is MARCKS protein phosphorylated by other fertilization-associated kinases; and (2) would these kinases be similarly inhibited by bisindolylmaleimide? There is more evidence to suggest that an increase in PKC activity occurs at fertilization since activation of PKC is often associated with a translocation to the plasma membrane from the cytoplasm. Such a transition can be observed in hamster oocytes using a fluorescent PKC binding agent Rim-1 (rhodamine conjugated indolylmaleimide) after treatment with Ca 2+ ionophore (Gallicano et al., 1995 (Gallicano et al., , 1997a and with spermatozoa (Gallicano et al., 1997a) . These data suggest, albeit with the abovementioned reservations, that activation of PKC can be observed at fertilization. Whether PKC is actually driving specific events such as polar body extrusion is not clear.
The protein kinase C family
PKC exists as a family of isoforms. However, there is no established evidence as yet about which members of the family are present in oocytes. The family comprises three groups characterized by their cofactor requirement and has been discussed in several recent excellent reviews (for example, Nishizuka, 1995; Jaken, 1996) . Briefly, there are conventional isoforms of PKC that require DAG for activation and are sensitive to Ca 2+ . Classically, activation of phospholipase C has been implicated in producing these second messengers both directly for DAG and indirectly through inositol trisphosphate (IP 3 ) for Ca 2+ . Other PKCs have been identified, which belong to the novel and atypical families, that make their activity either Ca 2+ -independent, or DAG-and Ca 2+ -independent, respectively. These isoforms require other cofactors for activation, such as ceramide, arachidonic acid and phosphatidylinositides (Nakanishi et al., 1993; Muller et al., 1995) . It appears that single members of the family can be involved in cellular processes (Otte and Moon, 1992; Watanabe et al., 1992; Borner et al., 1995) and their differing cofactor requirements underlie distinct functions.
It is often assumed that oocytes, like somatic cells, express at least one of the conventional isoforms of PKC. This assumption is wrong in at least one mouse strain in which only one isoform of the novel PKC (PKC-delta) and one isoform of the atypical PKC (PKC-lambda) is present (Gangeswaran and Jones, 1997) . With respect to oocytes, it is also of note that atypical PKCs do not have a DAG-binding domain and, therefore, are not activated by phorbol esters.
Signal transduction at fertilization
If the view is taken that the spermatozoon acts as a giant hormone molecule locking onto oolemma receptors that initiate the train of Ca 2+ oscillations in oocytes, then this mechanism is mediated by either a G-protein-coupled or tyrosine kinaselinked membrane receptor. In this model, PKC has a clearly defined place (see Fig. 2a ). However, there is little good evidence to suggest that IP 3 can mimic exactly the Ca 2+ oscillations at fertilization, which is central to this model (Swann, 1994; Jones and Whittingham, 1996) . Recent evidence suggests that a spermderived Ca 2+ -releasing factor is introduced directly into the ooplasm (Parrington et al., 1996) . This may be a way of activating intracellular Ca 2+ release channels independent of known receptor activators, such as IP 3 . This topic is outside the scope of the present review but has been debated elsewhere (for example, Swann and Lai, 1997) and does show that PKC may be activated indirectly, through an increase in intracellular Ca 2+ (Fig. 2b) . This may occur by a number of routes that all have Ca 2+ sensitivity: hydrolysis of phosphatidylcholine (PC) by PCdependent phospholipase C (PC-PLC; Billah and Anthes, 1990) and by phospholipase D (Anthes et al., 1989; Halenda and Rehm 1990) , and hydrolysis of phosphatidylinositol (PI) by PIdependent phospholipase (PI-PLC; Whitaker and Irvine, 1984; Nakanishi et al., 1985) . For both PI-PLC and PC-PLC, DAG is produced directly, whereas for PLD, the product is phosphatidic acid, which is dephosphorylated to DAG by a phosphohydrolase (Billah and Anthes, 1990) . PKC activation can be seen in sea urchin eggs at fertilization (Heinecke et al., 1990; Olds et al., 1995) . In sea urchin eggs, the switching on of phospholipase C through non-hydrolysable G-proteins causes, as expected, both PKC activation and an increase in Ca 2+ (Crossley et al., 1991) . PKC activation is assayed by its ability to switch on the Na-H antiporter responsible for causing alkalinization of sea urchin eggs at fertilization. When an increase in intracellular Ca 2+ is buffered by intracellular Ca 2+ chelating agents, the increase in Ca 2+ is blocked. In such buffered eggs after microinjection of non-hydrolysable Gproteins, the Na-H antiporter is still able to switch on because DAG is produced and PKC is activated (as in Fig. 2a) . However, in buffered eggs that are fertilized, there is no alkalinization, even though eggs become polyspermic; therefore, there is no activation of PKC. This suggests that there is a pathway in sea urchin eggs for DAG, through PKC, to switch on the Na-H exchanger but, at fertilization, the spermatozoon does not produce DAG until there is an increase in Ca 2+ concentration. In addition, there is evidence to suggest that the spermatozoon, at least in part, uses a Ca 2+ -calmodulin dependent kinase to switch on the exchanger (Shen, 1989) . It may be that, in both mammalian oocytes and sea urchin eggs, PKC is activated at fertilization as a consequence of the increase in Ca 2+ owing to release from intracellular stores (Fig. 2b) , rather than because of the bifurcating production of IP 3 and DAG by the fertilizing spermatozoon (Fig. 2a) .
Conclusions
It could be argued that the role of PKC in mammalian oocytes has been overstated. There is little general agreement that it is involved in any of the three processes associated with mammalian oocyte fertilization: namely, Ca 2+ oscillations, meiotic resumption and CG release. It has been suggested that PKC plays a pivotal role at fertilization and in the development of the embryo (Gallicano et al., 1997b) . Although there is good evidence to implicate PKC activation at fertilization, this review would argue against it necessarily driving fertilizationassociated events. However, individual members of the PKC family do appear to be important in many aspects of somatic cell signalling, such as growth and differentiation, and this may also be the case in oocytes. For example, PKC may mediate metaphase II arrest since members of the PKC family have been implicated in growth arrest in somatic cells (Watanabe et al., 1992; Mischak et al., 1993) . There are interactions of PKC with MAP kinase (Berra et al., 1995) , one of the components of cytostatic factor that helps maintain MPF integrity during metaphase arrest.
Many of the processes that PKC could be involved in have been overlooked because of the restricted signal transduction pathway PKC has been forced into during oocyte activation by the overuse of phorbol-and bisindolylmaleimide-based pharmacology. The first step must be to clarify which members of the family are present in oocytes and then to pursue their activity not only at fertilization but also during previous maturation and subsequent embryonic development. 
